Formononetin ameliorates isoproterenol induced cardiac fibrosis through improving mitochondrial dysfunction
Open Access
- 8 December 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 170, 116000
Abstract
No abstract availableKeywords
Funding Information
- Scientific Research Fund of Liaoning Provincial Education Department (LJKMZ20221267)
- Scientific Research Fund of Liaoning Provincial Education Department (LJKZ0840)
- Scientific Research Fund of Liaoning Provincial Education Department (LJKZ0847)
- National Natural Science Foundation of China (81900267)
This publication has 56 references indexed in Scilit:
- p53-PGC-1α Pathway Mediates Oxidative Mitochondrial Damage and Cardiomyocyte Necrosis Induced by Monoamine Oxidase-A Upregulation: Role in Chronic Left Ventricular Dysfunction in MiceAntioxidants & Redox Signaling, 2013
- Regulation of the Inflammatory Response in Cardiac RepairCirculation Research, 2012
- Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and -independent mechanismsActa Pharmacologica Sinica, 2011
- Oxidation of Myofibrillar Proteins in Human Heart FailureJACC, 2011
- Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophyHuman Molecular Genetics, 2010
- Network pharmacology: the next paradigm in drug discoveryNature Chemical Biology, 2008
- MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathwayFree Radical Biology and Medicine, 2007
- ECM remodeling in hypertensive heart diseaseJournal of Clinical Investigation, 2007
- Regulation of Matrix Metalloproteinases by Cytokines and Reactive Oxygen/Nitrogen Species in the MyocardiumHeart Failure Reviews, 2004
- A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissuesCell and tissue research, 2003